![Xun Zhu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 830 894 $ au 31/05/2026
Xun Zhu is currently an Independent Non-Executive Director at Medtide, Inc. since 2024, Sihuan Pharmaceutical Holdings Group Ltd. since 2014, and Lansen Pharmaceutical Holdings Ltd. since 2022.
Also holds the position of Non-Executive Director at Cathay International Pharmaceutical Ltd. since 2011 and Hightide Therapeutics, Inc. since 2020.
Serves as Deputy Director at China Medicinal Biotech Association, Vice Principal at Norman Bethune Medical University since 1995, and Member-Life Science Division at National Natural Science Foundation of China.
Former roles include Independent Non-Executive Director at Apollomics, Inc. (United States), Independent Director at Shenzhen Chipscreen Biosciences Co., Ltd., and Professor at Jilin University from 1994 to 2018.
Education includes a doctorate from Norman Bethune Medical University conferred in 1989.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2025 | 1 190 832 ( 0,21 % ) | 463 424 $ | 31/05/2026 | |
| 31/12/2024 | 3 000 000 ( 0,03 % ) | 367 470 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Directeur/Membre du Conseil | 20/02/2014 |
| LANSEN PHARMACEUTICAL HOLDINGS LIMITED | Directeur/Membre du Conseil | 23/09/2022 |
| HIGHTIDE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/11/2020 |
| MEDTIDE INC. | Directeur/Membre du Conseil | 23/05/2024 |
Cathay International Pharmaceutical Ltd. | Directeur/Membre du Conseil | 01/08/2011 |
China Medicinal Biotech Association | Corporate Officer/Principal | - |
Norman Bethune Medical University
 Norman Bethune Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1995 |
National Natural Science Foundation of China
 National Natural Science Foundation of China General GovernmentGovernment Engages in development of researches on sciences and technologies | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
Jilin University
 Jilin University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/06/2018 |
| ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Jilin University
Jilin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Norman Bethune Medical University
Norman Bethune Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sihuan Pharmaceutical Holdings Group Ltd.
 Sihuan Pharmaceutical Holdings Group Ltd. Pharmaceuticals: OtherHealth Technology Operates as a holding company which engages in research, development, manufacture and distribution of pharmaceuticals and medical aesthetic products | Health Technology |
Shenzhen Chipscreen Biosciences Co., Ltd.
 Shenzhen Chipscreen Biosciences Co., Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small molecule pharmaceuticals | Health Technology |
China Medicinal Biotech Association | |
National Natural Science Foundation of China
National Natural Science Foundation of China General GovernmentGovernment Engages in development of researches on sciences and technologies | Government |
Lansen Pharmaceutical Holdings Ltd.
 Lansen Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Functions as a holding company through its subsidiaries develops, manufactures and distributes rheumatic Western pharmaceuticals | Health Technology |
Cathay International Pharmaceutical Ltd. | |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops mono therapies and combination therapies of tumor-targeting and immuno-oncology agents | Health Technology |
Hightide Therapeutics, Inc.
 Hightide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of therapies for the treatment of metabolic and digestive diseases | Health Technology |
Taide Pharmaceutical (Zhejiang) Co., Ltd.
 Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Provides discovery, pre-clinical research, clinical development and production of drugs | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
